Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2016-10, Vol.27, p.vi26-vi26
Hauptverfasser: Zick, A., Peretz, T., Lotem, M., Hubert, A., Katz, D., Temper, M., Rottenberg, Y., Uziely, B., Nechushtan, H., Meirovitz, A., Sonnenblick, A., Sapir, E., Edelman, D., Goldberg, Y., Lossos, A., Rosenberg, S., Fried, I., Finklstein, R., Pikarsky, E., Goldshmidt, H.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page vi26
container_issue
container_start_page vi26
container_title Annals of oncology
container_volume 27
creator Zick, A.
Peretz, T.
Lotem, M.
Hubert, A.
Katz, D.
Temper, M.
Rottenberg, Y.
Uziely, B.
Nechushtan, H.
Meirovitz, A.
Sonnenblick, A.
Sapir, E.
Edelman, D.
Goldberg, Y.
Lossos, A.
Rosenberg, S.
Fried, I.
Finklstein, R.
Pikarsky, E.
Goldshmidt, H.
description
doi_str_mv 10.1093/annonc/mdw363.36
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw363_36</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419437204</els_id><sourcerecordid>S0923753419437204</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2746-e7bb0a1e9f05412ca810cc5d7a7ac21a48e7520336ac85d29a6e1f8d937ccef13</originalsourceid><addsrcrecordid>eNp1kL1OAzEQhC0EEiHQU_oFLrHP90uHIv6kSDShtjbrNRjd-YJ9Ccpz8MI4OlqK1Raj-WY0jN1KsZCiVUvwfvC47M23qtRCVWdsJsuqzRpRyHM2E22usrpUxSW7ivFTCFG1eTtjP5tAMPbkR-68pRDIcBuGnvf7EUY3-MidSaqzLin76Pw77yFGdyC-gwBdRx2P9LUnjyetIzCRjwPHznmH0PEtebLuhOdx6Il_EBxcd-S7QOMpO2ERPFJIvNGlqHjNLix0kW7-_py9PT5sVs_Z-vXpZXW_zjCviyqjersVIKm1oixkjtBIgViaGmrAXELRUF3mQqkKsClN3kJF0jamVTUiWanmTExcDEOMgazeBddDOGop9GlUPY2qp1F1ujm7myyUeh0cBR0xdUYyLhCO2gzuf_MvIhKHIg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Zick, A. ; Peretz, T. ; Lotem, M. ; Hubert, A. ; Katz, D. ; Temper, M. ; Rottenberg, Y. ; Uziely, B. ; Nechushtan, H. ; Meirovitz, A. ; Sonnenblick, A. ; Sapir, E. ; Edelman, D. ; Goldberg, Y. ; Lossos, A. ; Rosenberg, S. ; Fried, I. ; Finklstein, R. ; Pikarsky, E. ; Goldshmidt, H.</creator><creatorcontrib>Zick, A. ; Peretz, T. ; Lotem, M. ; Hubert, A. ; Katz, D. ; Temper, M. ; Rottenberg, Y. ; Uziely, B. ; Nechushtan, H. ; Meirovitz, A. ; Sonnenblick, A. ; Sapir, E. ; Edelman, D. ; Goldberg, Y. ; Lossos, A. ; Rosenberg, S. ; Fried, I. ; Finklstein, R. ; Pikarsky, E. ; Goldshmidt, H.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdw363.36</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2016-10, Vol.27, p.vi26-vi26</ispartof><rights>2016 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Zick, A.</creatorcontrib><creatorcontrib>Peretz, T.</creatorcontrib><creatorcontrib>Lotem, M.</creatorcontrib><creatorcontrib>Hubert, A.</creatorcontrib><creatorcontrib>Katz, D.</creatorcontrib><creatorcontrib>Temper, M.</creatorcontrib><creatorcontrib>Rottenberg, Y.</creatorcontrib><creatorcontrib>Uziely, B.</creatorcontrib><creatorcontrib>Nechushtan, H.</creatorcontrib><creatorcontrib>Meirovitz, A.</creatorcontrib><creatorcontrib>Sonnenblick, A.</creatorcontrib><creatorcontrib>Sapir, E.</creatorcontrib><creatorcontrib>Edelman, D.</creatorcontrib><creatorcontrib>Goldberg, Y.</creatorcontrib><creatorcontrib>Lossos, A.</creatorcontrib><creatorcontrib>Rosenberg, S.</creatorcontrib><creatorcontrib>Fried, I.</creatorcontrib><creatorcontrib>Finklstein, R.</creatorcontrib><creatorcontrib>Pikarsky, E.</creatorcontrib><creatorcontrib>Goldshmidt, H.</creatorcontrib><title>Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kL1OAzEQhC0EEiHQU_oFLrHP90uHIv6kSDShtjbrNRjd-YJ9Ccpz8MI4OlqK1Raj-WY0jN1KsZCiVUvwfvC47M23qtRCVWdsJsuqzRpRyHM2E22usrpUxSW7ivFTCFG1eTtjP5tAMPbkR-68pRDIcBuGnvf7EUY3-MidSaqzLin76Pw77yFGdyC-gwBdRx2P9LUnjyetIzCRjwPHznmH0PEtebLuhOdx6Il_EBxcd-S7QOMpO2ERPFJIvNGlqHjNLix0kW7-_py9PT5sVs_Z-vXpZXW_zjCviyqjersVIKm1oixkjtBIgViaGmrAXELRUF3mQqkKsClN3kJF0jamVTUiWanmTExcDEOMgazeBddDOGop9GlUPY2qp1F1ujm7myyUeh0cBR0xdUYyLhCO2gzuf_MvIhKHIg</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Zick, A.</creator><creator>Peretz, T.</creator><creator>Lotem, M.</creator><creator>Hubert, A.</creator><creator>Katz, D.</creator><creator>Temper, M.</creator><creator>Rottenberg, Y.</creator><creator>Uziely, B.</creator><creator>Nechushtan, H.</creator><creator>Meirovitz, A.</creator><creator>Sonnenblick, A.</creator><creator>Sapir, E.</creator><creator>Edelman, D.</creator><creator>Goldberg, Y.</creator><creator>Lossos, A.</creator><creator>Rosenberg, S.</creator><creator>Fried, I.</creator><creator>Finklstein, R.</creator><creator>Pikarsky, E.</creator><creator>Goldshmidt, H.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161001</creationdate><title>Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients</title><author>Zick, A. ; Peretz, T. ; Lotem, M. ; Hubert, A. ; Katz, D. ; Temper, M. ; Rottenberg, Y. ; Uziely, B. ; Nechushtan, H. ; Meirovitz, A. ; Sonnenblick, A. ; Sapir, E. ; Edelman, D. ; Goldberg, Y. ; Lossos, A. ; Rosenberg, S. ; Fried, I. ; Finklstein, R. ; Pikarsky, E. ; Goldshmidt, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2746-e7bb0a1e9f05412ca810cc5d7a7ac21a48e7520336ac85d29a6e1f8d937ccef13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zick, A.</creatorcontrib><creatorcontrib>Peretz, T.</creatorcontrib><creatorcontrib>Lotem, M.</creatorcontrib><creatorcontrib>Hubert, A.</creatorcontrib><creatorcontrib>Katz, D.</creatorcontrib><creatorcontrib>Temper, M.</creatorcontrib><creatorcontrib>Rottenberg, Y.</creatorcontrib><creatorcontrib>Uziely, B.</creatorcontrib><creatorcontrib>Nechushtan, H.</creatorcontrib><creatorcontrib>Meirovitz, A.</creatorcontrib><creatorcontrib>Sonnenblick, A.</creatorcontrib><creatorcontrib>Sapir, E.</creatorcontrib><creatorcontrib>Edelman, D.</creatorcontrib><creatorcontrib>Goldberg, Y.</creatorcontrib><creatorcontrib>Lossos, A.</creatorcontrib><creatorcontrib>Rosenberg, S.</creatorcontrib><creatorcontrib>Fried, I.</creatorcontrib><creatorcontrib>Finklstein, R.</creatorcontrib><creatorcontrib>Pikarsky, E.</creatorcontrib><creatorcontrib>Goldshmidt, H.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zick, A.</au><au>Peretz, T.</au><au>Lotem, M.</au><au>Hubert, A.</au><au>Katz, D.</au><au>Temper, M.</au><au>Rottenberg, Y.</au><au>Uziely, B.</au><au>Nechushtan, H.</au><au>Meirovitz, A.</au><au>Sonnenblick, A.</au><au>Sapir, E.</au><au>Edelman, D.</au><au>Goldberg, Y.</au><au>Lossos, A.</au><au>Rosenberg, S.</au><au>Fried, I.</au><au>Finklstein, R.</au><au>Pikarsky, E.</au><au>Goldshmidt, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients</atitle><jtitle>Annals of oncology</jtitle><date>2016-10-01</date><risdate>2016</risdate><volume>27</volume><spage>vi26</spage><epage>vi26</epage><pages>vi26-vi26</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdw363.36</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2016-10, Vol.27, p.vi26-vi26
issn 0923-7534
1569-8041
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdw363_36
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A31%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20inferred%20from%20mutations%20identified%20using%20massive%20parallel%20sequencing%20leads%20to%20clinical%20benefit%20in%20some%20heavily%20pretreated%20cancer%20patients&rft.jtitle=Annals%20of%20oncology&rft.au=Zick,%20A.&rft.date=2016-10-01&rft.volume=27&rft.spage=vi26&rft.epage=vi26&rft.pages=vi26-vi26&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdw363.36&rft_dat=%3Celsevier_cross%3ES0923753419437204%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419437204&rfr_iscdi=true